Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bonella

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 6, 2020
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasisEleftheria Chorti, Theodora Kanaki, Lisa Zimmer, et al.
Journal of Thoracic Imaging|August 26, 2024
Automated 3D-Body Composition Analysis as a Predictor of Survival in Patients With Idiopathic Pulmonary FibrosisLuca Salhöfer, Francesco Bonella, Mathias Meetschen, et al.
BMC Veterinary Research|December 10, 2015
Pulmonary alveolar proteinosis in a catViktor Szatmári, Erik Teske, Peter G J Nikkels, et al.
Frontiers in Medicine|August 23, 2021
Patient Reported Experiences and Delays During the Diagnostic Pathway for Pulmonary Fibrosis: A Multinational European SurveyIris G van der Sar, Steve Jones, Deborah L Clarke, et al.
Scientific Reports|October 9, 2025
Serum KL-6 as a biomarker to predict progression at one year in interstitial lung diseaseFrancesco Bonella, M C Vegas Sanchez, M d'Alessandro, et al.
Orphanet Journal of Rare Diseases|December 19, 2012
KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndromeYoshiko Kida, Shinichiro Ohshimo, Kohei Ota, et al.
Journal of Clinical Medicine|November 28, 2019
Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort StudyChihiro Hirano, Shinichiro Ohshimo, Yasushi Horimasu, et al.
Pneumologie (Stuttgart, Germany)|March 14, 2023
[SARS-CoV-2-Infection and Interstitial Lung Disease: Position paper of the German Respiratory Society]Jürgen Behr, Melanie Berger, Torsten Gerriet Blum, et al.
Pneumologie (Stuttgart, Germany)|March 1, 2023
[Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis - S2k Guideline of the German Respiratory Society]Jürgen Behr, Francesco Bonella, Björn C Frye, et al.
Respiration; International Review of Thoracic Diseases|September 9, 2024
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses: S2k Guideline of the German Respiratory SocietyJürgen Behr, Francesco Bonella, Björn Christian Frye, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|April 6, 2020
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasisEleftheria Chorti, Theodora Kanaki, Lisa Zimmer, et al.
Journal of Thoracic Imaging|August 26, 2024
Automated 3D-Body Composition Analysis as a Predictor of Survival in Patients With Idiopathic Pulmonary FibrosisLuca Salhöfer, Francesco Bonella, Mathias Meetschen, et al.
BMC Veterinary Research|December 10, 2015
Pulmonary alveolar proteinosis in a catViktor Szatmári, Erik Teske, Peter G J Nikkels, et al.
Frontiers in Medicine|August 23, 2021
Patient Reported Experiences and Delays During the Diagnostic Pathway for Pulmonary Fibrosis: A Multinational European SurveyIris G van der Sar, Steve Jones, Deborah L Clarke, et al.
Scientific Reports|October 9, 2025
Serum KL-6 as a biomarker to predict progression at one year in interstitial lung diseaseFrancesco Bonella, M C Vegas Sanchez, M d'Alessandro, et al.
Orphanet Journal of Rare Diseases|December 19, 2012
KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndromeYoshiko Kida, Shinichiro Ohshimo, Kohei Ota, et al.
Journal of Clinical Medicine|November 28, 2019
Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort StudyChihiro Hirano, Shinichiro Ohshimo, Yasushi Horimasu, et al.
Pneumologie (Stuttgart, Germany)|March 14, 2023
[SARS-CoV-2-Infection and Interstitial Lung Disease: Position paper of the German Respiratory Society]Jürgen Behr, Melanie Berger, Torsten Gerriet Blum, et al.
Pneumologie (Stuttgart, Germany)|March 1, 2023
[Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis - S2k Guideline of the German Respiratory Society]Jürgen Behr, Francesco Bonella, Björn C Frye, et al.
Respiration; International Review of Thoracic Diseases|September 9, 2024
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses: S2k Guideline of the German Respiratory SocietyJürgen Behr, Francesco Bonella, Björn Christian Frye, et al.
Pageof 20